DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Logunov DY, Dolzhikova IV, Shcheblyakov DV. et al; Gam-COVID-Vac Vaccine Trial Group.
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Lancet 2021;
397 (10275): 671-681
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.